PrimeRFP SCOUT · Federal Contract Recompete Brief

36C26023F0144Berotralstat — Biocryst Pharmaceuticals, Inc

The prior award was single-bid — competitive dynamics may favor a challenge. PoP ended Jan 19, 2024 — the usual 12–18 month planning window is closed; recompete action looks late or overdue.

260-Network Contract Office 20 (36C260)

Awarding office

Biocryst Pharmaceuticals, Inc

Recipient

Jan 19, 2024

PoP end

$340K

Obligated

$340K

Potential

325412

NAICS

6505

PSC

1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal

Contract number36C26023F0144

Also listed as36C260-23-F-0144

Also listed as36F79721D0166-36C26023F0144

Agency260-Network Contract Office 20 (36C260)

Awarding office260-Network Contract Office 20 (36C260)

Awarding agencyDepartment of Veterans Affairs (VA)

Funding agencyDepartment of Veterans Affairs (VA)

IncumbentBiocryst Pharmaceuticals, Inc

CAGE4GBX7

UEIMGXADJ6SCLJ5

NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6505

Parent IDIQ / IDV36F79721D0166

Place of performanceROSEBURG OR

Pricing typeFirm Fixed Price

Extent competedFull And Open Competition

PoP startJan 20, 2023

PoP end (current)Jan 19, 2024

Obligated$340K

Current value$340K

Potential value$340K

BEROTRALSTAT is a federal award for 260-Network Contract Office 20 (36C260) held by Biocryst Pharmaceuticals, Inc. Estimated value $340K ($340K obligated). Current period of performance ends Jan 19, 2024. Last award drew 1 bidder. Place of performance: ROSEBURG OR.

Recompete timing

Public

● Past PoP end (986 days ago)

Current PoP ended Jan 19, 2024 (986 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.

Bonuses end Sept 30

Want the durability read on 36C26023F0144? One Pursuit Analysis, $500, inside 48 business hours.

48 business hours
$500
Credits toward the Pack

Buy one Pursuit Analysis — $500

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

Frequently asked questions

What is contract 36C26023F0144?

36C26023F0144 (Berotralstat) is a 260-Network Contract Office 20 (36C260) award with a potential value of $340K, currently held by Biocryst Pharmaceuticals, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

What is 36C260-23-F-0144?

36C260-23-F-0144 is the dashed form of PIID 36C26023F0144 (Berotralstat), held by Biocryst Pharmaceuticals, Inc. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.

Which office awarded 36C26023F0144?

260-Network Contract Office 20 (36C260) awarded 36C26023F0144 to Biocryst Pharmaceuticals, Inc (potential $340K).

Who is the incumbent on 36C26023F0144?

Biocryst Pharmaceuticals, Inc is the incumbent. The current period of performance ends Jan 19, 2024.

When does Biocryst Pharmaceuticals, Inc’s 36C26023F0144 come up for recompete?

SCOUT tracks a period-of-performance end of Jan 19, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 36C26023F0144? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of Jan 20, 2023 · refreshed monthly